Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
Amos Gitonga Mbaabu, Associate Programme Manager-Southern Africa at Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, shared a post on LinkedIn:
“Strengthening care and advocacy for haemophilia and sickle cell disease across Southern Africa!
Back home from South Africa, I’m reflecting on a week of regional learning, advocacy and collaboration.
Proud that the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation brought together partners from South Africa, Botswana, Namibia, Malawi, Lesotho, Zambia and Zimbabwe to strengthen care and advocacy for people living with haemophilia and sickle cell disease.
We started with a two-day advocacy workshop, addressing some of the region’s key challenges: underdiagnosis, limited access to treatment and gaps in sustainable diagnostic infrastructure.
Together, we explored how to turn evidence and existing policy commitments into concrete advocacy action.
From the WHA Resolution on haemophilia and other bleeding disorders and the Africa CDC Continental Plan for Sickle Cell Disease and Other Inherited Blood Disorders to the potential role of SADC, we discussed opportunities to strengthen advocacy at national and regional levels.
The week continued with the South African Haemophilia Foundation MASAC Educational Symposium 2026, held under the theme ‘Thinking Outside The Box’.
The symposium brought together haemophilia care teams from South Africa and the wider region for clinical education, research exchange and multidisciplinary collaboration.
For healthcare professionals from neighbouring countries, this was an opportunity to learn from South Africa’s experience and identify approaches they could adapt locally.
Discussions covered treatment access, haemophilia treatment centres, patient registries, physiotherapy, psychosocial support and multidisciplinary care.
What stood out was the willingness to share practical experiences, learn from one another and identify opportunities for stronger regional collaboration.
The next step is to build on these exchanges, translate shared priorities into country-led action and strengthen collaboration across Southern Africa.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?
-
Nov 17, 2026, 23:33Remi Remakanth: The Role of Transfusion Medicine in HLA Antibody Testing and Transplant Desensitization
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency